Daniel S. Pratt, MD
Assistant Professor of Medicine
Harvard Medical School
| Address: | Massachusetts General Hospital Blake 4 55 Fruit St. Boston, MA 02114 |
| Patient Appointments: | (617) 726-3313 |
| Academic Phone: | (617) 724-6113 |
| Fax: | (617) 724-6832 |
| Clinical Background: | |
| MD Degree: | Johns Hopkins University School of Medicine 1985-1989 |
| Residency: | Tufts-New England Medical Center 1989-1992 |
| Fellowship: | Tufts-New England Medical Center 1992-1995 |
| Board Certifications: | Internal Medicine, 1992 Gastroenterology, 1995 |
Clinical Interests:
- Cholestatic Liver Disease
- Primary Biliary Cirrhosis
- Primary Sclerosing Cholangitis
- Viral Hepatitis
- Cirrhosis/Endstage Liver Disease
- Liver Transplantation
- Hepatocellular Carcinoma
- Cholangiocarcinoma
Recent Publications:
- Pratt DS. Cholestasis and cholestatic syndromes. Current Opinion in Gastroenterology 2005;21:270-274.
- Kowdley KV, Pratt DS. Adiponectin - Tipping the Scales From NAFLD to NASH? Gastroenterology 2005;128:511-513.
- Amin MG, Wolf MP, Tenbrook JA Jr., Freeman RB Jr., Cheng SJ, Pratt DS, Wong JB, Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: a decision analysis. Liver Transpl. 2004 Dec;10(12):1468-75.
- Leung JY, Zhu AX, Gordon FD, Pratt DS, Mithoefer A, Garrigan K, Terella T, Hertl M, Cosimi AB, Chung RT. Liver Transplantation Outcomes for Early-Stage Hepatocellular Carcinoma: Results of a Multicenter Study. Liver Transplantation 2004;10:1343-1354.
- Demetriou AA, Brown RS Jr., Busuttil RW, Fair J, McGuire BM, Rosenthal P, Am Esch JS 2nd, Lerut J, Nyberg SL, Salizzoni M, Fagan EA. de Hemptinne B, Broelsch CE, Muraca M, Salmeron JM, Rabkin JM, Metselaar HJ, Pratt D, De La Mata M, McChesney LP, Everson GT, Lavin PT, Stevens AC, Pitkin Z, Solomon BA. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Annals of Surgery 2004;239:660-7.
- Epstein SK, Freeman RB, Khayat A, Unterborn JN, Pratt DS, Kaplan MM. Aerobic capacity is associated with 100-day outcome after hepatic transplantation. Liver Transplantation 2004;10:418-424.
- Pratt DS, Kaplan MM. Evaluation of Abnormal Liver Enzyme Tests in the Asymptomatic Patient. New England Journal of Medicine, 2000;342:1266-1271.
